ciprofloxacin has been researched along with Marchiafava-Micheli Syndrome in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martinez-Mera, C | 1 |
| Montes-Torres, A | 1 |
| Gordillo-Vélez, C | 1 |
| Sánchez-Pérez, J | 1 |
1 other study available for ciprofloxacin and Marchiafava-Micheli Syndrome
| Article | Year |
|---|---|
Ecthyma Gangrenosum in Paroxysmal Nocturnal Hemoglobinuria.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Ciprofloxacin; Ecthyma; Female; Hemoglobin | 2018 |